Filing Flows › Ingevity (NGVT) › Capital expenditures
Ingevity (NGVT) capital expenditures by quarter
Ingevity's capital expenditures were $13.7M in Q3 2026 (third quarter 2026), -42% from Q4 2025. Over the last 5 quarters it ranged from $10.0M (Q1 2025) to $23.6M (Q4 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $13.7M | -42% | +15% |
| Q4 2025 | $23.6M | +98% | — |
| Q3 2025 | $11.9M | -2% | — |
| Q2 2025 | $12.2M | +22% | — |
| Q1 2025 | $10.0M | — | — |
Q3 2026 at a glance
Ingevity, Q3 2026: revenue $305M (-8% year over year), operating margin 22.0%, net earnings $49.3M, operating cash flow $99.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is Ingevity's capital expenditures?
Ingevity's capital expenditures were $13.7M in Q3 2026 (third quarter 2026), -42% from Q4 2025.
How has Ingevity's capital expenditures changed?
Over the last 5 quarters it ranged from $10.0M (Q1 2025) to $23.6M (Q4 2025).